Leukemia/Lymphoma/Myeloma Panel by Flow Cytometry

No evidence of monoclonal B cell population
A flow cytometry result stating "No evidence of monoclonal B-cell population" indicates that there are no abnormal or clonal populations of B-cells detected in the analyzed sample. Here's a breakdown of what this result means: 1. Monoclonal B-Cell Population: In this context, monoclonal B-cell population refers to a group of B-cells that are identical or nearly identical, indicating the presence of abnormal cells. This can be indicative of various hematologic disorders, including certain types of leukemia or lymphoma. 2. No Evidence: The phrase "No evidence" signifies that the test did not find any abnormalities or clonal populations of B-cells in your sample. This is a reassuring result, as it suggests that your B-cell population appears normal and there are no signs of hematologic neoplasms or malignancies. 3. Clinical Significance: A "No evidence of monoclonal B-cell population" result is generally considered a normal finding. It indicates that there are no indications of hematologic disorders involving B-cells at the time of the test. However, it's important to note that medical interpretations can vary based on individual clinical contexts and the specific reason for the flow cytometry test. 4. Monitoring: If you underwent flow cytometry for monitoring purposes due to a prior hematologic condition, a "No evidence" result suggests that there is no evidence of disease recurrence or progression in terms of B-cell abnormalities. It's important to discuss the results with your healthcare provider, who can provide personalized guidance based on your medical history and the reason for the test. They will help you understand the significance of the result in your specific case.
Evidence of monoclonal B-cell population
If the result of a Leukemia/Lymphoma/Myeloma Panel by Flow Cytometry indicates "Evidence of monoclonal B-cell population," it suggests that there is a presence of B-cells (a type of white blood cell) that are identical and derived from a single original cell. This finding is significant as it may indicate a clonal proliferation, which is a hallmark of certain types of blood cancers, such as lymphoma or leukemia. In normal conditions, B-cells are polyclonal, meaning they come from various origins. The detection of a monoclonal population typically warrants further investigation to determine the specific type and nature of the hematological disorder, guiding appropriate treatment and management strategies.

The Leukemia/Lymphoma/Myeloma Panel by Flow Cytometry is a specialized diagnostic test used in the field of hematology (=the study of blood and blood disorders) to analyze and classify various blood and bone marrow disorders, including: 

→ Leukemia (Leukemia is a broad term for cancers of the blood cells)

→ Lymphoma (a broad term for cancer that begins in cells of the lymph system)

→ and Myeloma (a cancer of the plasma cells).

This test employs flow cytometry, a laser-based technique that enables the precise examination of the physical and chemical characteristics of individual cells. It involves staining white blood cells with monoclonal antibodies that target specific antigens on the cell surface, allowing for the identification and classification of different cell types.

By scrutinizing the expression patterns of these antigens, healthcare professionals can obtain crucial information about the lineage, phenotype, and abnormal cell populations present in a patient's blood or bone marrow.

This diagnostic tool aids in making accurate diagnoses, guiding treatment decisions, and monitoring disease progression. It is particularly valuable for identifying subtle abnormalities in cell populations, facilitating early detection and more tailored management of hematologic disorders.

--------------------

Here are some helpful insights into how to interpret your results:

CD19 Positive B Cells: CD19 is a common marker for B cells. If the result is low it suggests that these CD19 positive B cells are present in a small quantity.

No Detectable Monoclonality: The absence of monoclonality means that these CD19 positive B cells do not appear to be clonal or derived from a single cell, which is a characteristic often associated with hematologic neoplasms such as leukemia or lymphoma.

A certain % is CD45 Negative: CD45 is a marker commonly found on immune cells, including B cells. The fact that a certain percentage of the events are CD45 negative could indicate the presence of other cell types or a variation in the expression of CD45 on these cells.

To fully interpret this result, it is crucial to correlate it with the clinical and laboratory information available. The context provided by the your medical history, symptoms, and other diagnostic tests will help healthcare professionals determine the significance of these findings.

Leukemia/Lymphoma/Myeloma Panel by Flow Cytometry
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Leukemia/Lymphoma/Myeloma Panel by Flow Cytometry — 10,000+ markers explained
One Leukemia/Lymphoma/Myeloma Panel by Flow Cytometry result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro